Member Info for BertieBassett

Yes

-- BB --

Does anyone know what is our "day countdown" figure? Should be soon ...

-- BB --

Thank you!

-- BB --

Https://screenrec.com/share/7EeGDZWujq

Hello! Can anyone advise? Were the trades in black buys or sells?

Thanks!

-- BB --

It seems that the science is sound and IB - in particular - knows what it is doing. Having MS and KS at the helm in Wisconsin is a boon. They are well-respected in the US - in both the business and scientific communities and rightly so.

BUT it also seems that the "business" - IQAI - has issues - as you say RJH27 - comms, shareholder "care" etc is severely lacking.

One can only hope that as TB has so much experience with multiple companies in BRH, that he can carry off any and all opportunities that are thrown our way.

Looking at the IQAI website, Brett Skelly is of great interest. Yes, he works for BRH as well but states that he has "Assisted several clients to successfully sell their businesses". One can only hope ...

-- BB --

In the end, as the old adage goes, follow the money ....

Will be of great interest to see who has bought up the FAB/TB stock that has been off-loaded.

Will be of great interest to see where IQAI is financially. Do we need a fundraise or are we making enough?

I guess we will know soon enough.

-- BB --

Addendum:

In June 2019, IQ-AI Limited raised £250,000 through a placing of 7,142,857 new ordinary shares at a price of 3.5p each.

If the Company does need cash, this current level of SP will allow it to raise ... but hopefully not.

-- BB --

TB - 23.23%

KS - 5.23%

FAB - 3.68%

(from IQAI website - figures from 19/1)

In past years, TB & FAB have had much bigger slice of the company. We have all discussed this magical "30%" mark that TB stays just under ... he is now way under that (I believe that FAB is now in his son's name?). Historically, TB has been quite fastidious in keeping The Browns close but not touching the 30%.

Could it be that for a shark to swallow the minnow there needs to be less "family ownership"?

Could it be that TB is actually "encouraging" P.I.s to get involved before an offer comes in from an external party?

I note that KS still has her 5% and MS must have a small slice too (no selling there).

If this company was going to the wall, KS & MS would be selling too ... (KS slice worth around £300k).

Just a few thoughts ...

-- BB --

This link may help - https://screenrec.com/share/h3IL0wNVY1

note that it is virtually up to date (19.01.2024)

-- BB --

Jimzi,

The scientists/co-founders at Imaging Biometrics - Kathleen and Michael Schmainda - have a sizeable chunk of IQAI stock ...

-- BB --

I am not the biggest fan of "how" this company is run BUT if TB wanted to go private, he would have done so a while ago ... he can't just say "I am going private" and its fait accomplit. He must also know that the voucher-news is imminent ... any day ... so to go private after the news (hopefully positive!) would be crazy.

Also, other "major" sharholders are US-based and that has its own implications.

We go through this every January.... and yes, it is unsettling if you are a trader ... but for the LTHs (like myself), this is just part & parcel of the investment churn. Stay positive and keep buying in the dips. In the end, when this company goes private/bought/sold etc etc, the more stock you have (at this price), the better!

-- BB--

Would be a delight if its Bayer ... or even one of our US friends - Michael, Katherine etc ... but at this stage, anyone or company that is associated with pharma/biotech would be great for SP and shareholder sentiment ...

-- BB --

Jan 21st 2022 - 6.25 (year high 6.75 to low 1.65)

Jan 21st 2023 - 3 (year high 5.8 to low 1.8)

Jan 21st 2024 - 3 (year high 5.05 to 3 the moment ... )

Have we REALLY lost 40% of the SP in juts a few days???

It's all rather disappointing for the majority .... although it seems the minority is benefiting ...

-- BB --

X (Twit)

-- BB --

Https://t.co/WSG12zpR4g

-- BB --

Tyke,

Yes ... it is rather intriguing.

The USA is key to the future of IQ-AI and that's where the focus is.

The Team out there is doing the stirling work and TB is watching and commenting from afar. I think this maybe a good thing.

I note that BRH (Braveheart) is whimpering along too with the same shareholder "complaints" of how they are being treated. Its highs of 128.5p in 2021 to 9p today must be of great stress for its LTHs.

We are in a situation now that for first-timers, this is a GREAT buy-in price ... but for us LTHs, this is just another (and sadly once-too-often) period of negativity ...

Still - we must remember that a) volume is low so the pendulum swings deeply both ways b) we have received periodic good news (FDA etc) which in most companies would see a huge & sustained SP rise ... we can only hope our time comes sooner rather than later ..

-- BB --

Gosh, I know how you feel ... BUT I am not sure he is just "going to walk" as there are too many stakeholders involved and indeed he has worked quite hard to get this far.

I did email TB late last year asking whether he would be conducting any interviews and he stated "I have no plans to be interviewed, but I do have plans to let shareholders judge the company by its performance over the next couple of years" ...

So let's see whether he is a man of his words ...

-- BB --

Https://t.co/MP9JLKorNY

-- BB --

Https://mailchi.mp/imagingbiometrics/optimization-of-surgical-targets-in-neurosurgery-17642043

A great read ...

-- BB --

Imaging Biometrics, LLC (IB), a wholly owned subsidiary of IQ-AI Ltd (LSE: IQAI, OTCBB: IQAIF), is launching an intermediate population cohort expanded access program (EAP) for oral gallium maltolate (GaM), subject to FDA approval. The EAP will be for brain tumor patients located throughout the United States who are unable to participate in the phase 1 clinical trial on-going at the Medical College of Wiscsonsin (MCW). The FDA's recent Fast Track Designation for GaM serves as the motivation behind this launch.

** subject to FDA approval **

-- BB --